Associação para Investigação e Desenvolvimento da Faculdade de Medicina

Where the EU money came from

Funding by EU programme. Amounts are Associação para Investigação e Desenvolvimento da Faculdade de Medicina's own share of each project, not the project's full budget.

Projects

13 EU-funded projects, newest first. Associação para Investigação e Desenvolvimento da Faculdade de Medicina led 1 of them as coordinator. Each links to the official record.

• FH-EARLYCoordinator

  NEW STRATEGIES FOR THE EARLY DIAGNOSIS, RISK STRATIFICATION AND CO-MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €885ktheir share
• GRIPonMASHPartner

  GRIP on MASH: Global Research Initiative for Patient Screening on MASH

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €640ktheir share
• acaSTEMyAssociated partner

  Trans-national STEM teacher education focussing on transversal competence and sustainability education

  Erasmus+ (ERASMUS+) · 2023–2026 · Project on the EU portal ↗
• ImmuHubsPartner

  Innovative Immunisation Hubs

  3rd Health Programme · 2021–2024 · Project on the EU portal ↗

  €57ktheir share
• ICU4CovidPartner

  Cyber-Physical Intensive Care Medical System for Covid-19

  Horizon 2020 · 2021–2022 · Project on CORDIS ↗

  €160ktheir share
• CoroPreventionAssociated partner

  Personalized Prevention for Coronary Heart Disease

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• c4cPartner

  conect4children (COllaborative Network for European Clinical Trials For Children)

  Horizon 2020 · 2018–2025 · Project on CORDIS ↗

  €1.8Mtheir share
• MEDIRADPartner

  Implications of Medical Low Dose Radiation Exposure

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €445ktheir share
• NEVERMINDPartner

  NEurobehavioural predictiVE and peRsonalised Modelling of depressIve symptoms duriNg primary somatic Diseases with ICT-enabled self-management procedures

  Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  €521ktheir share
• BETA3_LVHPartner

  A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

  Horizon 2020 · 2015–2022 · Project on CORDIS ↗

  €222ktheir share
• MyCyFAPPPartner

  Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool.

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  €318ktheir share
• FFPPartner

  Families and food poverty in three European Countries in an Age of Austerity

  FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

  €12ktheir share
• COPHESPartner

  European coordination action on human biomonitoring

  FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

  €24ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
• Karolinska InstitutetSweden · 3 shared projects
• Servicio Madrileno de SaludSpain · 3 shared projects
• Katholieke Universiteit LeuvenBelgium · 2 shared projects
• Consiglio Nazionale Delle RicercheItaly · 2 shared projects
• Universiteit GentBelgium · 2 shared projects
• University College LondonUnited Kingdom · 2 shared projects
• Charite - Universitaetsmedizin BerlinGermany · 2 shared projects
• Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
• Stichting Amsterdam UmcNetherlands · 2 shared projects
• Terveyden Ja Hyvinvoinnin LaitosFinland · 2 shared projects
• University of Newcastle Upon TyneUnited Kingdom · 2 shared projects
• Tartu UlikoolEstonia · 2 shared projects
• Assistance Publique Hopitaux de ParisFrance · 2 shared projects
• Istituto Superiore di SanitaItaly · 2 shared projects
• Ecrin European Clinical Research Infrastructure NetworkFrance · 2 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• alcohols
• arteriosclerosis
• breast cancer
• business models
• cardiovascular diseases
• coronaviruses
• critical care medicine
• databases
• diagnostic imaging
• drug discovery
• employment
• enzymes
• epidemiology
• hepatology